Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

11.60p
   
  • Change Today:
    -0.78p
  • 52 Week High: 17.60p
  • 52 Week Low: 1.09p
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 3,961,499
  • Market Cap: £58.32m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £172,662
Lisa Baderoon 583,963 £67,740
Tim Franklin 525,000 £60,900

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 25,108,044 £2,912,533
Luca & Associates AG 22,000,000 £2,552,000
Invesco Ltd 17,872,341 £2,073,192
Aviva Investors Global 11,285,180 £1,309,081
Alora Pharmaceuticals LLC 10,909,091 £1,265,455
M&G Investments 7,600,000 £881,600
Prudential plc 7,600,000 £881,600
Capital Income Builder 4,870,367 £564,963
Dr R Zimmer 4,551,553 £527,980
Odey Asset Management 3,433,319 £398,265
Rhone Trustees (Switzerland) SA 3,386,000 £392,776
Pictet Overseas Trust Corporation Limited 3,287,500 £381,350

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 11.60p
Change Today -0.78p
% Change -6.26 %
52 Week High 17.60p
52 Week Low 1.09p
Volume 3,961,499
Shares Issued 502.72m
Market Cap £58.32m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 24-Oct-2025

Time Volume / Share Price
16:30 77 @ 10.70p
16:30 125 @ 10.70p
16:30 112 @ 10.70p
16:30 64 @ 11.80p
15:50 100,000 @ 10.95p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page